14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $141.98 $159.34 Friday, 3rd May 2024 ALNY stock ended at $152.33. This is 1.34% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 2.30% from a day low at $151.91 to a day high of $155.41.
90 days $141.98 $173.18
52 weeks $141.98 $218.88

Historical Alnylam Pharmaceuticals prices

Date Open High Low Close Volume
May 13, 2020 $144.96 $146.54 $137.94 $139.46 857 770
May 12, 2020 $143.18 $149.24 $140.04 $144.19 833 864
May 11, 2020 $136.71 $144.20 $135.42 $142.43 899 268
May 08, 2020 $142.58 $143.12 $135.86 $136.13 707 013
May 07, 2020 $144.14 $145.71 $139.78 $141.45 1 048 200
May 06, 2020 $141.24 $151.84 $137.49 $145.27 2 229 257
May 05, 2020 $137.53 $143.18 $137.05 $141.23 735 490
May 04, 2020 $130.54 $136.77 $129.02 $136.63 892 342
May 01, 2020 $130.45 $131.37 $124.95 $128.97 525 539
Apr 30, 2020 $136.27 $138.33 $131.57 $131.70 677 349
Apr 29, 2020 $140.01 $141.76 $132.91 $135.81 651 115
Apr 28, 2020 $142.43 $142.89 $136.64 $137.50 626 613
Apr 27, 2020 $147.28 $147.41 $142.27 $142.70 486 112
Apr 24, 2020 $143.75 $147.00 $141.80 $145.63 690 647
Apr 23, 2020 $139.82 $144.41 $139.82 $141.64 1 092 006
Apr 22, 2020 $140.00 $141.74 $137.72 $140.11 383 334
Apr 21, 2020 $144.50 $146.56 $135.17 $137.85 1 198 431
Apr 20, 2020 $136.62 $146.08 $135.49 $144.87 1 467 661
Apr 17, 2020 $131.74 $138.70 $130.25 $138.48 1 386 070
Apr 16, 2020 $123.32 $128.97 $120.25 $127.72 894 757
Apr 15, 2020 $117.73 $124.48 $116.94 $121.50 448 420
Apr 14, 2020 $121.14 $124.20 $119.67 $120.72 802 259
Apr 13, 2020 $120.00 $120.05 $114.30 $119.01 1 175 312
Apr 09, 2020 $110.74 $117.10 $110.74 $116.38 567 665
Apr 08, 2020 $104.75 $114.34 $103.65 $111.39 737 374
Click to get the best stock tips daily for free!

About Alnylam Pharmaceuticals

Alnylam Pharmaceuticals Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system (CNS)/ocular diseases. Its marketed products include ONPATTRO (patisiran), a lipid complex injection f... ALNY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT